2.44
0.03 (1.24%)
| Penutupan Terdahulu | 2.41 |
| Buka | 2.42 |
| Jumlah Dagangan | 354,542 |
| Purata Dagangan (3B) | 464,912 |
| Modal Pasaran | 68,558,216 |
| Harga / Pendapatan (P/E Ke hadapan) | 9.80 |
| Harga / Jualan (P/S) | 174.38 |
| Harga / Buku (P/B) | 2.90 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 17 Nov 2025 |
| EPS Cair (TTM) | -1.96 |
| Nisbah Semasa (MRQ) | 0.220 |
| Aliran Tunai Operasi (OCF TTM) | -10.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 3.23 M |
| Pulangan Atas Aset (ROA TTM) | -191.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | NRX Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.88 |
|
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 15.88% |
| % Dimiliki oleh Institusi | 13.34% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Chicago Partners Investment Group Llc | 30 Sep 2025 | 41,994 |
| One Wealth Management Investment & Advisory Services, Llc | 30 Sep 2025 | 27,991 |
| Ethos Financial Group, Llc | 30 Sep 2025 | 11,900 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 47.00 (Ascendiant Capital, 1,826.23%) | Beli |
| Median | 37.00 (1,416.39%) | |
| Rendah | 25.00 (BTIG, 924.59%) | Beli |
| Purata | 36.50 (1,395.90%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 2.72 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 03 Dec 2025 | 25.00 (924.59%) | Beli | 2.41 |
| D. Boral Capital | 03 Dec 2025 | 34.00 (1,293.44%) | Beli | 2.41 |
| 02 Dec 2025 | 34.00 (1,293.44%) | Beli | 2.27 | |
| Ascendiant Capital | 30 Oct 2025 | 47.00 (1,826.23%) | Beli | 3.02 |
| HC Wainwright & Co. | 16 Oct 2025 | 40.00 (1,539.34%) | Beli | 3.04 |
| 01 Oct 2025 | 40.00 (1,539.34%) | Beli | 3.34 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |